(Q44640634)

English

In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa)

scientific article published on November 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa) (English)

1 reference

10.1038/SJ.BMT.1704275

https://api.crossref.org/works/10.1038/SJ.BMT.1704275

27 March 2024

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

J. Bouligand

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595385

27 March 2024

I. Boland

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595385

27 March 2024

D. Valteau-Couanet

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595385

27 March 2024

A. Deroussent

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595385

27 March 2024

C. Kalifa

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595385

27 March 2024

O. Hartmann

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595385

27 March 2024

G. Vassal

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595385

27 March 2024

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

https://www.nature.com/articles/1704275

1 reference

10.1038/SJ.BMT.1704275

https://api.crossref.org/works/10.1038/SJ.BMT.1704275

27 March 2024

https://www.nature.com/articles/1704275.pdf

Portable Document Format

1 reference

10.1038/SJ.BMT.1704275

https://api.crossref.org/works/10.1038/SJ.BMT.1704275

27 March 2024

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

979-986

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704275

0 references

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Avoiding hepatic veno-occlusive disease: what do we know and where are we going?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Aspects concerning busulfan pharmacokinetics and bioavailability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Target dose adjustment of busulfan in pediatric patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

PKCALC: a BASIC interactive computer program for statistical and pharmacokinetic analysis of data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Plasma concentration monitoring of busulfan: does it improve clinical outcome?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Role of multidrug resistance protein 1 (MRP1) and glutathione S-transferase A1-1 in alkylating agent resistance. Kinetics of glutathione conjugate formation and efflux govern differential cellular sensitivity to chlorambucil versus melphalan toxicit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Potentiation of the cytostatic effect of melphalan on colorectal cancer hepatic metastases by infusion of buthionine sulfoximine (BSO) in the rat: enhanced tumor glutathione depletion by infusion of BSO in the hepatic artery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Evaluation of existing limited sampling models for busulfan kinetics in children with beta thalassaemia major undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

21 January 2018

Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic monitoring of busulfan in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

7 January 2021

based on heuristic

inferred from DOI database lookup

Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

7 January 2021

based on heuristic

inferred from DOI database lookup

Gas chromatographic-mass spectrometric assay for busulfan in biological fluids using a deuterated internal standard

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of high-dose busulfan in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

7 January 2021

based on heuristic

inferred from DOI database lookup

Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose melphalan with autotransplantation for refractory multiple myeloma: results of a Southwest Oncology Group phase II trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

7 January 2021

based on heuristic

inferred from DOI database lookup

Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704275

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug Metabolism and Disposition

37

24

1015

author name string

M Czerwinski

publication date

1996

1 reference

10.1038/SJ.BMT.1704275

https://api.crossref.org/works/10.1038/SJ.BMT.1704275

27 March 2024

Identifiers

10.1038/SJ.BMT.1704275

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44640634&oldid=2144133861"